Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

NCT: NCT05724173 · RECRUITING

NCT IDNCT05724173
StatusRECRUITING
Start Date2023-10-18
Completion2027-07-31
SponsorLeigh R. Hochberg, MD, PhD. (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

Frequently Asked Questions

What is Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia?

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia is a clinical trial registered under NCT05724173. Current status: RECRUITING.

What is the status of NCT05724173?

The current status of NCT05724173 (Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia) is: RECRUITING.

When did Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia start?

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia started on 2023-10-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.